ETIAS.info Takes the Guesswork Out of Navigating the ETIAS Process
BARCELONA, SPAIN / ACCESSWIRE / August 7, 2021 / It is no secret that travel…
Month: August 2021
Expression of Interest for Construction of University Hospital Project in Kenya
VANCOUVER, BC / ACCESSWIRE / August 17, 2021 / Minaean SP Construction Corp. (TSXV:MSP)(Berlin and…
Mike Edwards Is the Subject of a New Interview
The career corporate executive sat down with a freelance journalist to discuss his life, his…
MorphoSys’ Partner Incyte Announced Development and Commercialization Agreement with InnoCare for Tafasitamab in Greater China
PLANEGG and MUNICH, GERMANY / ACCESSWIRE / August 17, 2021 / MorphoSys AG (FSE:MOR; NASDAQ:MOR)…
Alzecure Gives Live Streamed Strategy Update on Alzheimer’s Disease and NeuroreStore on September 1
STOCKHOLM, SE / ACCESSWIRE / August 17, 2021 / AlzeCure Pharma (STO:ALZCUR) (FRA:AC6) AlzeCure Pharma…
Aduro Clean Technologies Announces Investor Relations Agreement with Digitonic Limited
SARNIA, ON / ACCESSWIRE / August 17, 2021 / Aduro Clean Technologies Inc. (CSE:ACT)(OTCQB:ACTHF)(FSE:9D50) (the…
StageZero Life Sciences Signs Definitive Agreement with Health Clinics Limited
StageZero to Expand Capabilities in Early Diagnosis and Prevention of Cancer and Other Diseases as…
Spark Power Builds Momentum Throughout Quarter; Optimistic About Second Half Performance
Second Quarter revenue grows 41.1% Year over Year to $65.4 million Renewables segment continues strong…
Neos Networks transforms Perth & Kinross Council’s infrastructure with the completion of its DCMS-funded Local Full Fibre Network project
Delivery achieved significantly ahead of schedule, despite the need to navigate challenges such as the…
Oxurion NV – Publication of Positive Phase 1 Clinical Data evaluating THR-687 for Treatment of DME in Ophthalmology Science, the American Academy of Ophthalmology Journal
THR-687 is a potent pan-RGD integrin antagonist holding potential as next generation first line therapy…
Tiziana Announces Publication of a Peer Reviewed Article on Data from the Clinical Trial with Intranasally Administered Foralumab, Its Proprietary Fully Human Anti-CD3 Monoclonal Antibody, in Mild to Moderate COVID-19 Patients in Brazil
Nasally administered Foralumab, once a day for 10 consecutive days, was well-tolerated and produced significant…
Basilea reports strong financial results for half-year 2021 with significantly increased cash flow from marketed brands and increases 2021 full-year guidance
CHF 46.1 million (+26% year-on-year) non-deferred Cresemba and Zevtera revenue, including CHF 23.6 million royalty…
Orion will remain as the owner of pharmaceutical manufacturing plant in Kuopio, Finland
ORION CORPORATION PRESS RELEASE 17 AUGUST 2021 at 8.00. a.m. EEST Orion will…
Telix Progresses Novel Lung and Ovarian Cancer Theranostic APOMAB®
MELBOURNE, Australia and ADELAIDE, Australia, Aug. 17, 2021 (GLOBE NEWSWIRE) — Telix Pharmaceuticals Limited (ASX:…
Telix’s TLX66 in Phase II Academic Study of Pediatric Leukemia
MELBOURNE, Australia and LONDON , Aug. 17, 2021 (GLOBE NEWSWIRE) — Telix Pharmaceuticals Limited (ASX:…
Medexus Pharmaceuticals Reports Financial and Operational Results for First Quarter Fiscal 2022
Continued strength in unit demand across key product lines Rupall unit demand growth of 44%…
Chalice Brands Ltd. To Present at the Q3 Virtual Investor Summit
PORTLAND, Ore., Aug. 16, 2021 (GLOBE NEWSWIRE) — Chalice Brands Ltd., formerly Golden Leaf Holdings…
Celularity Reports Second Quarter 2021 Financial Results
Secured funding of approximately $138 million through merger and private placement investment in public equity…
Zogenix Reports Granting of Inducement Awards
EMERYVILLE, Calif., Aug. 16, 2021 (GLOBE NEWSWIRE) — Zogenix (NASDAQ: ZGNX) today announced that the compensation…
Corvus Pharmaceuticals Announces IND Acceptance for Phase 1/1b Clinical Trial of CPI-818 in China
Corvus Partner Angel Pharmaceuticals Plans to Initiate Trial by Year-end 2021 BURLINGAME, Calif., Aug. 16,…